StockStory.org on MSN
Q1 earnings outperformers: Bio-Techne (NASDAQ:TECH) and the rest of the research tools & consumables stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Merck KGaA has agreed to acquire Bio-Techne (NasdaqGS:TECH) for $11.5b in an all cash deal. Bio-Techne's board has unanimously approved the transaction, which is now subject to regulatory review. The ...
Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.
View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results